Study Comparing EBUS & EUS to Mediastinoscopy in Staging and Detection of Lung Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

2 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-02-28

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a prospective randomized clinical trial with the study cohort comprised of all male and female patients over the age of 21 presenting to the study site for evaluation of lung cancer. The study will enroll 300 subjects, with 150 in each arm. Three sites will be in the study, Mayo Rochester, Mayo Jacksonville and Medical University of South Carolina. Mayo Rochester will enroll approximately 125 subjects. This study does not require subjects to undergo any additional procedures than what they would receive per standard medical care. The consenting subjects will receive EUS and /or EBUS- guided FNA or Mediastinoscopy/Thoracoscopy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Combined Application of EBUS and EUS in Lung Cancer

NCT01385111

Non Small Cell Lung Cancer

COMPLETED NA

Ultrathin Bronchoscope and Radial Endobronchial Ultrasound (R-EBUS) With Fluoroscopy Versus Standard Fiberoptic Bronchoscopy (FB) (P00029233 )

NCT02146131

Pulmonary Lesions Pulmonary Nodules Pulmonary Mass

COMPLETED NA

Needle-Based Confocal Laser Endomicroscopy for Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules

NCT05556525

Lung Carcinoma

TERMINATED NA

Clinical Impact of EUS in Staging NSCLC

NCT00577746

Non Small Cell Lung

COMPLETED

Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)

NCT00832715

Lung Cancer

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective randomized clinical trial of males and females age 21 or older being evaluated for lung cancer. The study will enroll approximately 300 subjects (150 in each arm) at 3 participating centers (MUSC, Mayo Clinic Rochester and Jacksonville). This sample size will provide sufficient statistical power (i.e. \>80%) using a non-inferiority study design with 1-sided hypothesis testing (Farrington and Manning 1990) to determine whether or not the sensitivity of the EUS/EBUS diagnostic technique is inferior (i.e. 10% or more lower) when compared to the sensitivity of malignant mediastinal adenopathy of about 40%. This study requires subjects to agree to the selection of their standard of care procedure. Subjects will be randomized (stratified computer generated randomization stratified y center and y CT positivity for pathologically enlarged \[\>1cm short axis\] node - 10 strata). Randomization will use variable block sizes (4-8), so that randomization allocation remains concealed as investigators will not be blinded. This study requires subjects to consent to the release of outcome data and follow-up data to be used for study analysis. No additional visit will be required for this study; this study will not require any additional time requirements beyond their scheduled evaluations.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non Small Cell Lung Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

traditional mediastinoscopy/thoracoscopy

Traditional Mediastinoscopy used to detect or stage lung cancers.

Group Type ACTIVE_COMPARATOR

Mediastinoscopy/thoracoscopy

Intervention Type PROCEDURE

Mediastinoscopy used to detect/stage lung cancer.

EBUS/EUS

Minimal invasive technique for staging/detecting lung cancer.

Group Type ACTIVE_COMPARATOR

EBUS/EUS

Intervention Type PROCEDURE

Minimal invasive technique to stage/detect lung cancer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mediastinoscopy/thoracoscopy

Mediastinoscopy used to detect/stage lung cancer.

Intervention Type PROCEDURE

EBUS/EUS

Minimal invasive technique to stage/detect lung cancer.

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lung biopsy Endobronchial Ultrasound Endoscopic Ultrasound

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 21 years or greater
* Pt is a surgical candidate for mediastinoscopy, thoracoscopy, or lung resection
* Known or suspected non-small cell carcinoma of the lung eligible for resection
* CT scan performed within 45 days prior to evaluation for study participation
* PET scan performed within 45 days prior to evaluation for study participation

Exclusion Criteria

* Pathologically proven metastatic disease
* History of malignancy within 5 years other than (skin) basal cell carcinoma
* Enlarged ipsilateral mediastinal lymph nodes \> 2.5 cm in diameter
* Peripheral T1 tumors with normal mediastinal lymph nodes on CT and PET

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No